Survival outcomes in metastatic castration-resistant prostate cancer in the up-front treatment era.

被引：0
|
作者：
Kamijo, Shunsuke
Naito, Yushi
Kato, Masashi
Yamamoto, Akiyuki
Tsuzuki, Toyonori
机构：
[1] Nagoya Univ, Grad Sch Med, Nagoya, Japan
[2] Nagoya Univ Hosp, Dept Urol, Nagoya, Japan
[3] Nagoya Univ, Grad Sch Med, Showa Ku, Nagoya, Japan
[4] Toyohashi Municipal Hosp, Toyohashi, Japan
[5] Aichi Med Univ, Nagakute, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
336
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamide
    Baciarello, Giulia
    Sternberg, Cora N.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 106 : 14 - 24
  • [22] Cabazitaxel: A New Treatment for Metastatic Castration-Resistant Prostate Cancer
    Schwartz, Joanna R.
    Bottiglieri, Salvatore M.
    AMERICAN JOURNAL OF LIFESTYLE MEDICINE, 2013, 7 (01) : 66 - 72
  • [23] RADIUM 223 FOR THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Miranda, Jesus
    Vinal, David
    Pinto, Alvaro
    ARCHIVOS ESPANOLES DE UROLOGIA, 2019, 72 (05): : 500 - 507
  • [24] Metastatic castration-resistant prostate cancer: integrating new learnings to optimise treatment outcomes
    Heidenreich, A.
    Porres, D.
    Piper, C.
    Thissen, A. K.
    Pfister, D.
    MINERVA UROLOGICA E NEFROLOGICA, 2013, 65 (03) : 171 - 187
  • [25] Factors influencing survival in metastatic castration-resistant prostate cancer therapy
    Marchioni, Michele
    Marandino, Laura
    Amparore, Daniele
    Berardinelli, Francesco
    Mascitti, Marco
    Ferro, Matteo
    Campi, Riccardo
    Schips, Luigi
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (10) : 1061 - 1079
  • [26] Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer
    Kreis, Kristine
    Horenkamp-Sonntag, Dirk
    Schneider, Udo
    Zeidler, Jan
    Glaeske, Gerd
    Weissbach, Lothar
    BJU INTERNATIONAL, 2022, 129 (04) : 470 - 479
  • [27] Predictors of overall survival in patients with metastatic castration-resistant prostate cancer
    Markova, A. S.
    Polikarpova, S. B.
    Kamolov, B. Sh.
    Gridneva, Ya. V.
    Kalinin, S. A.
    Peters, M. V.
    Matveev, V. B.
    ONKOUROLOGIYA, 2015, 11 (02): : 77 - 84
  • [28] Metastatic Castration-resistant Prostate Cancer: Piling Up the Benefits of Chemotherapy
    Tombal, Bertrand
    EUROPEAN UROLOGY, 2015, 68 (02) : 236 - 237
  • [29] Olaparib in Metastatic Castration-Resistant Prostate Cancer
    Biswas, Bivas
    Ganguly, Sandip
    Ghosh, Joydeep
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12): : 1174 - 1175
  • [30] Biomarkers in Metastatic Castration-resistant Prostate Cancer
    Miller, K.
    AKTUELLE UROLOGIE, 2015, 46 (01) : 66 - 70
12345